SourcePeptides reserves the right to refuse sale to any individual or entity that does not comply with these terms.
One six-month, randomized, double-blinded, placebo-controlled trial found that taking oral glutathione at either 250 or 1,000 mg/day led to significant increases in the body stores of glutathione in a dose-dependent manner
Studies have demonstrated its ability to stimulate collagen and glycosaminoglycan synthesis, attract immune cells to sites of injury, and modulate gene expression related to tissue remodeling
Most claimed synergy, where measured at all, turns out to be additivity
Some patients report that the compounded formulation seems gentler on their stomach compared to their experience with brand-name tirzepatide, though whether this is due to the niacinamide, different excipients, or placebo effect remains unclear
Please note that BPC-157 is strictly classified as a research chemical and is not approved for human consumption or therapeutic use